Yttrium-90 microspheres are a medical technology for treating cancer. Specifically, they usually refer to yttrium [90Y] glass microspheres or yttrium-90 resin microspheres. The microspheres contain the radioactive isotope yttrium-90 and have a very small diameter of about 20 to 30 microns, which is about one-third the width of a human hair.
During the treatment, doctors use vascular intervention to deliver millions of these microspheres to the liver tumor site and implant them inside the tumor. Yttrium-90 can emit pure beta rays. The average penetration distance of these rays in human tissue is about 2.5mm, which can kill tumor cells at close range while reducing damage to normal liver tissue and adjacent organs. Therefore, this treatment method is more direct and precise, and can avoid the side effects of traditional radiation therapy to the greatest extent.
Yttrium-90 microsphere injection was approved for marketing by the National Medical Products Administration (NMPA) on February 9, 2022, providing a new and effective treatment method for a large number of patients with liver malignant tumors in China, and also marking a milestone for China’s liver cancer The field of malignant tumors has ushered in a new international precision interventional treatment plan.
According to the new market research report “Yttrium-90 Microspheres- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030”, published by QYResearch, the global Yttrium-90 Microspheres market size is projected to reach USD 0.47 billion by 2030, at a CAGR of 11.1% during the forecast period.
- Global Yttrium-90 Microspheres MarketSize(US$ Million), 2019-2030
Source: QYResearch, "Yttrium-90 Microspheres- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030”
- Global Yttrium-90 Microspheres Top2 Players Rankingand Market Share (Ranking is based on the revenue of 2023, continually updated)
Source: QYResearch, "Yttrium-90 Microspheres- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030”
According to QYResearch Top Players Research Center, the global key manufacturers of Yttrium-90 Microspheres include Sirtex Medical, Boston Scientific Corporation, etc. In 2023, the global top three players had a share approximately 100.0% in terms of revenue.
- Yttrium-90 Microspheres,Global Market Size, Split by Product Segment
Source: QYResearch, "Yttrium-90 Microspheres- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030”
In terms of product type, currently Resin Microspheres is the largest segment, hold a share of 77.3%.
- Yttrium-90 Microspheres,Global Market Size, Split by ApplicationSegment
Source: QYResearch, "Yttrium-90 Microspheres- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030”
In terms of product application, currently Liver Cancer Treatment is the largest segment, hold a share of 94.4%.
- Yttrium-90 Microspheres,Global Market Size, Split by Region
Source: QYResearch, "Yttrium-90 Microspheres- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030”
Market Drivers:
With the aging of the population and changes in lifestyle, the incidence of tumors is increasing year by year, especially in areas such as liver cancer and colorectal cancer. Traditional treatment methods are often difficult to achieve satisfactory results. Yttrium-90 microsphere therapy, as an innovative treatment method, can provide new treatment options for these patients and meet the growing treatment needs in the market.
Yttrium-90 microsphere treatment technology combines the latest research results in multiple medical fields such as nuclear medicine, interventional radiology, oncology, etc., and achieves effective killing of tumors through precise positioning and high-dose radiation. With the continuous advancement of these medical technologies, the efficacy and safety of yttrium-90 microsphere therapy have been continuously improved, thus promoting their widespread clinical application.
Restraint:
The research, development and application of yttrium-90 microsphere technology involves many complex fields, including medicine, physics, engineering, etc., and requires profound professional knowledge and technical strength. This makes it difficult for some small businesses or institutions that lack relevant technology to get involved in this field, thus limiting the number of participants in the industry and the expansion of the market size.
The production and preparation process of yttrium-90 microspheres is relatively complex and involves high-precision manufacturing processes and expensive raw materials. In addition, due to its innovative and professional nature, the cost of treatment is relatively high, which may make it impossible for some patients with limited financial conditions to receive yttrium-90 microsphere treatment. High costs may become an important factor restricting the development of the industry.
Trends:
Yttrium-90 microspheres, as a new anti-cancer treatment method in China, have just been officially introduced from abroad by Yuanda Pharmaceutical in 2022. At the same time, related domestic research and drug development are also in full swing, and more and more companies are pouring into yttrium. 90 In the microsphere market, many drugs have begun clinical trials. Domestic companies can take advantage of the mature domestic supply chain, low costs, and broad market demand to quickly complete the local replacement of yttrium-90 microspheres.
Compared with resin microspheres, glass microspheres themselves contain Y-89 components, which have stable performance, good spheroidization, chemical inertness, and non-toxicity. Their physical and chemical properties remain unchanged after high-flux neutron bombardment. Microspheres have a large specific gravity and are easy to deposit, but the radioactive activity per unit microsphere is high and the number of microspheres required is small. Therefore, the embolization effect on tumor blood vessels is small, and it can also reduce the occurrence of ectopic embolism caused by reflux. Rate. In March 2021, the FDA approved Boston Scientific's TheraSphere Y90 glass microspheres for the treatment of patients with unresectable hepatocellular carcinoma (HCC). The glass microsphere market is growing rapidly.
About QYResearch
QYResearch founded in California, USA in 2007.It is a leading global market research and consulting company. With over 17 years’ experience and professional research team in various cities over the world QY Research focuses on management consulting, database and seminar services, IPO consulting, industry chain research and customized research to help our clients in providing non-linear revenue model and make them successful. We are globally recognized for our expansive portfolio of services, good corporate citizenship, and our strong commitment to sustainability. Up to now, we have cooperated with more than 60,000 clients across five continents. Let’s work closely with you and build a bold and better future.
QYResearch is a world-renowned large-scale consulting company. The industry covers various high-tech industry chain market segments, spanning the semiconductor industry chain (semiconductor equipment and parts, semiconductor materials, ICs, Foundry, packaging and testing, discrete devices, sensors, optoelectronic devices), photovoltaic industry chain (equipment, cells, modules, auxiliary material brackets, inverters, power station terminals), new energy automobile industry chain (batteries and materials, auto parts, batteries, motors, electronic control, automotive semiconductors, etc.), communication industry chain (communication system equipment, terminal equipment, electronic components, RF front-end, optical modules, 4G/5G/6G, broadband, IoT, digital economy, AI), advanced materials industry Chain (metal materials, polymer materials, ceramic materials, nano materials, etc.), machinery manufacturing industry chain (CNC machine tools, construction machinery, electrical machinery, 3C automation, industrial robots, lasers, industrial control, drones), food, beverages and pharmaceuticals, medical equipment, agriculture, etc.
Contact Us:
If you have any queries regarding this report or if you would like further information, please contact us:
QY Research Inc.
Add: 17890 Castleton Street Suite 369 City of Industry CA 91748 United States
E-mail: global@qyresearch.com
Tel: 001-626-842-1666(US) 0086-133 1872 9947(CN)
EN: https://www.qyresearch.com
JP: https://www.qyresearch.co.jp